Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Proteasome inhibitors].

¹Service de médecine interne, unité d'oncologie médicale, groupe hospitalier Cochin-Saint-Vincent-de-Paul, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. jerome.alexandre@cch.ap-hop-paris.fr

La Revue De Medecine Interne

|September 1, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Pressure ulcer following compression otoplasty garment: A rare but severe case report].

Annales de chirurgie plastique et esthetique·2026

Same author

[Fasciitis-like primary breast pyoderma gangrenosum: A rare case report].

Annales de chirurgie plastique et esthetique·2026

Same author

Declining research interest among oncology residents: insights into the academic career from a nationwide longitudinal study in France.

ESMO open·2026

Same author

Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study.

ESMO open·2025

Same author

Search for Highly Ionizing Particles in pp Collisions during LHC Run 2 Using the Full MoEDAL Detector.

Physical review letters·2025

Same author

Annales de cardiologie et d'angeiologie·2025

Same journal

[Atypical low back pain].

La Revue de medecine interne·2026

Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026

Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026

Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026

Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026

Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026

See all related articles

Proteasome inhibition, using bortezomib, shows promise in treating lymphoid cancers. While effective in some blood cancers, its use in solid tumors is limited by side effects, but it may enhance other cancer therapies.

Area of Science:

Oncology
Molecular Biology
Pharmacology

Background:

The proteasome regulates cell cycle and apoptosis, and its dysregulation is implicated in cancer development.
Bortezomib, a proteasome inhibitor, is approved for multiple myeloma and mantle cell lymphoma.
Adverse events like neurotoxicity can limit bortezomib's long-term application.

Purpose of the Study:

To review the role of proteasome inhibition in cancer therapy.
To discuss the efficacy and limitations of bortezomib.
To explore potential combination strategies involving bortezomib.

Main Methods:

Review of preclinical data and clinical trial outcomes for bortezomib.
Analysis of proteasome function in cell cycle and apoptosis.

Related Experiment Videos

Evaluation of bortezomib's therapeutic effects and adverse events.

Main Results:

Bortezomib demonstrates significant antitumor activity in multiple myeloma and mantle cell lymphoma.
Modest efficacy of bortezomib as a single agent in solid tumors.
Preclinical evidence suggests bortezomib can potentiate the activity of cytotoxic agents.

Conclusions:

Proteasome inhibition represents a viable therapeutic strategy, particularly for hematologic malignancies.
Further research is warranted to optimize bortezomib use and overcome limitations in solid tumors.
Combination therapies may enhance the clinical utility of proteasome inhibitors.